Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Apr;67(4):1090-1091.
doi: 10.1007/s10620-021-07106-y. Epub 2021 Jun 28.

Covid-19 and Patients with IBD: Who Is at Highest Risk for Severe Complications?

Sara Horst  1
Affiliations
Editorial

Covid-19 and Patients with IBD: Who Is at Highest Risk for Severe Complications?

Sara Horst. Dig Dis Sci. 2022 Apr.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Brenner EJ, Ungaro RC, Gearry RB, et al. Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry. Gastroenterology. 2020;159:481–491 e483. doi: 10.1053/j.gastro.2020.05.032. - DOI - PMC - PubMed
    1. Aziz M, Fatima R, Haghbin H, Lee-Smith W, Nawras A. The incidence and outcomes of COVID-19 in IBD patients: a rapid review and meta-analysis. Inflamm Bowel Dis. 2020;26:e132–e133. doi: 10.1093/ibd/izaa170. - DOI - PMC - PubMed
    1. Khan N, Patel D, Xie D, Pernes T, Lewis J, Yang YX. Are patients with inflammatory bowel disease at an increased risk of developing SARS-CoV-2 than patients without inflammatory bowel disease? results from a nationwide veterans' affairs cohort study. Am J Gastroenterol. 2021;116:808–810. doi: 10.14309/ajg.0000000000001012. - DOI - PubMed
    1. Singh S, Khan A, Chowdhry M, Bilal M, Kochhar GS, Clarke K. Risk of severe coronavirus disease 2019 in patients with inflammatory bowel disease in the United States: a multicenter research network study. Gastroenterology. 2020;159:1575–1578 e1574. doi: 10.1053/j.gastro.2020.06.003. - DOI - PMC - PubMed
    1. Ungaro RC, Brenner EJ, Gearry RB, et al. Effect of IBD medications on COVID-19 outcomes: results from an international registry. Gut. 2021;70:725–732. doi: 10.1136/gutjnl-2020-322539. - DOI - PMC - PubMed